Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials

Dale C. Hesdorffer, Jacqueline A. French, Kelly Posner, Bree Diventura, John R. Pollard, Michael R. Sperling, Cynthia L. Harden, Gregory L. Krauss, Andres M Kanner

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Summary Purpose Three suicidal ideation and suicidal behavior instruments were used to assess the prevalence of lifetime and recent suicidal ideation and suicidal behavior in patients with frequent treatment-resistant focal seizures who would be eligible for randomized clinical trials. This was done to determine which instrument was optimal for use in epilepsy. Methods In a cross-sectional study, we compared lifetime and recent suicidal ideation and suicide attempt on the MINI International Neuropsychiatric Interview (MINI), Columbia Suicide Severity Rating Scale (C-SSRS), and Interactive Voice Response System CSSRS (E-CSSRS). A safety algorithm determined treatment referral. Coordinators and participants evaluated experiences with the C-SSRS. The proportion of participants that baseline assessment would exclude from clinical trial enrollment was determined. Key Findings Among 208 participants, 1.6-3.9% had recent high risk suicidal ideation and 1.0-4.7% had a recent suicide attempt across all instruments. Lifetime high-risk suicidal ideation occurred in 12.1-14.1%. Lifetime suicide attempt occurred in 10.2-13.1% of participants. Of those with recent suicide attempt, 31.1% required referral to a health professional, and 3.9% needed urgent referral. Lifetime suicidal behavior (including aborted suicide attempt, interrupted suicide attempt, suicide attempt, preparatory acts or behavior, and nonsuicidal self-injurious behavior) was found in 21.1% on the E-CSSRS and 15.5% on the C-SSRS. Agreement (Kappa) was good to excellent for comparisons of all instruments. Fifty-two percent of subjects preferred either the CSSRS or E-CSSRS, whereas the rest had no preference; of those having a preference, 87.5% favored the CSSRS. Of the 18.9% of participants who might have been excluded from trials based on suicidal ideation and suicide attempt, the CSSRS identified high-risk suicidal ideation or suicide attempt in the preceding 2 years in only 4.4%. Significance Suicidality screening is feasible in people with epilepsy. Slightly more suicidal behavior is reported with the E-CSSRS than C-SSRS, suggesting the E-CSSRS may be optimal. The proportion of patients who may be excluded from clinical trials based on worrisome suicidal ideation or suicide attempt is small, suggesting that it is possible to enroll most eligible individuals.

Original languageEnglish (US)
Pages (from-to)879-887
Number of pages9
JournalEpilepsia
Volume54
Issue number5
DOIs
StatePublished - May 2013
Externally publishedYes

Fingerprint

Suicidal Ideation
Partial Epilepsy
Suicide
Pharmaceutical Preparations
Referral and Consultation
Drug Resistant Epilepsy
Epilepsy
Clinical Trials
Self-Injurious Behavior

Keywords

  • CSSRS
  • Epilepsy
  • MINI
  • Suicidal behavior
  • Suicidal ideation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Hesdorffer, D. C., French, J. A., Posner, K., Diventura, B., Pollard, J. R., Sperling, M. R., ... Kanner, A. M. (2013). Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials. Epilepsia, 54(5), 879-887. https://doi.org/10.1111/epi.12128

Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials. / Hesdorffer, Dale C.; French, Jacqueline A.; Posner, Kelly; Diventura, Bree; Pollard, John R.; Sperling, Michael R.; Harden, Cynthia L.; Krauss, Gregory L.; Kanner, Andres M.

In: Epilepsia, Vol. 54, No. 5, 05.2013, p. 879-887.

Research output: Contribution to journalArticle

Hesdorffer, DC, French, JA, Posner, K, Diventura, B, Pollard, JR, Sperling, MR, Harden, CL, Krauss, GL & Kanner, AM 2013, 'Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials', Epilepsia, vol. 54, no. 5, pp. 879-887. https://doi.org/10.1111/epi.12128
Hesdorffer DC, French JA, Posner K, Diventura B, Pollard JR, Sperling MR et al. Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials. Epilepsia. 2013 May;54(5):879-887. https://doi.org/10.1111/epi.12128
Hesdorffer, Dale C. ; French, Jacqueline A. ; Posner, Kelly ; Diventura, Bree ; Pollard, John R. ; Sperling, Michael R. ; Harden, Cynthia L. ; Krauss, Gregory L. ; Kanner, Andres M. / Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials. In: Epilepsia. 2013 ; Vol. 54, No. 5. pp. 879-887.
@article{1fc5f78a983d46ccb285385e46daadf9,
title = "Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials",
abstract = "Summary Purpose Three suicidal ideation and suicidal behavior instruments were used to assess the prevalence of lifetime and recent suicidal ideation and suicidal behavior in patients with frequent treatment-resistant focal seizures who would be eligible for randomized clinical trials. This was done to determine which instrument was optimal for use in epilepsy. Methods In a cross-sectional study, we compared lifetime and recent suicidal ideation and suicide attempt on the MINI International Neuropsychiatric Interview (MINI), Columbia Suicide Severity Rating Scale (C-SSRS), and Interactive Voice Response System CSSRS (E-CSSRS). A safety algorithm determined treatment referral. Coordinators and participants evaluated experiences with the C-SSRS. The proportion of participants that baseline assessment would exclude from clinical trial enrollment was determined. Key Findings Among 208 participants, 1.6-3.9{\%} had recent high risk suicidal ideation and 1.0-4.7{\%} had a recent suicide attempt across all instruments. Lifetime high-risk suicidal ideation occurred in 12.1-14.1{\%}. Lifetime suicide attempt occurred in 10.2-13.1{\%} of participants. Of those with recent suicide attempt, 31.1{\%} required referral to a health professional, and 3.9{\%} needed urgent referral. Lifetime suicidal behavior (including aborted suicide attempt, interrupted suicide attempt, suicide attempt, preparatory acts or behavior, and nonsuicidal self-injurious behavior) was found in 21.1{\%} on the E-CSSRS and 15.5{\%} on the C-SSRS. Agreement (Kappa) was good to excellent for comparisons of all instruments. Fifty-two percent of subjects preferred either the CSSRS or E-CSSRS, whereas the rest had no preference; of those having a preference, 87.5{\%} favored the CSSRS. Of the 18.9{\%} of participants who might have been excluded from trials based on suicidal ideation and suicide attempt, the CSSRS identified high-risk suicidal ideation or suicide attempt in the preceding 2 years in only 4.4{\%}. Significance Suicidality screening is feasible in people with epilepsy. Slightly more suicidal behavior is reported with the E-CSSRS than C-SSRS, suggesting the E-CSSRS may be optimal. The proportion of patients who may be excluded from clinical trials based on worrisome suicidal ideation or suicide attempt is small, suggesting that it is possible to enroll most eligible individuals.",
keywords = "CSSRS, Epilepsy, MINI, Suicidal behavior, Suicidal ideation",
author = "Hesdorffer, {Dale C.} and French, {Jacqueline A.} and Kelly Posner and Bree Diventura and Pollard, {John R.} and Sperling, {Michael R.} and Harden, {Cynthia L.} and Krauss, {Gregory L.} and Kanner, {Andres M}",
year = "2013",
month = "5",
doi = "10.1111/epi.12128",
language = "English (US)",
volume = "54",
pages = "879--887",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials

AU - Hesdorffer, Dale C.

AU - French, Jacqueline A.

AU - Posner, Kelly

AU - Diventura, Bree

AU - Pollard, John R.

AU - Sperling, Michael R.

AU - Harden, Cynthia L.

AU - Krauss, Gregory L.

AU - Kanner, Andres M

PY - 2013/5

Y1 - 2013/5

N2 - Summary Purpose Three suicidal ideation and suicidal behavior instruments were used to assess the prevalence of lifetime and recent suicidal ideation and suicidal behavior in patients with frequent treatment-resistant focal seizures who would be eligible for randomized clinical trials. This was done to determine which instrument was optimal for use in epilepsy. Methods In a cross-sectional study, we compared lifetime and recent suicidal ideation and suicide attempt on the MINI International Neuropsychiatric Interview (MINI), Columbia Suicide Severity Rating Scale (C-SSRS), and Interactive Voice Response System CSSRS (E-CSSRS). A safety algorithm determined treatment referral. Coordinators and participants evaluated experiences with the C-SSRS. The proportion of participants that baseline assessment would exclude from clinical trial enrollment was determined. Key Findings Among 208 participants, 1.6-3.9% had recent high risk suicidal ideation and 1.0-4.7% had a recent suicide attempt across all instruments. Lifetime high-risk suicidal ideation occurred in 12.1-14.1%. Lifetime suicide attempt occurred in 10.2-13.1% of participants. Of those with recent suicide attempt, 31.1% required referral to a health professional, and 3.9% needed urgent referral. Lifetime suicidal behavior (including aborted suicide attempt, interrupted suicide attempt, suicide attempt, preparatory acts or behavior, and nonsuicidal self-injurious behavior) was found in 21.1% on the E-CSSRS and 15.5% on the C-SSRS. Agreement (Kappa) was good to excellent for comparisons of all instruments. Fifty-two percent of subjects preferred either the CSSRS or E-CSSRS, whereas the rest had no preference; of those having a preference, 87.5% favored the CSSRS. Of the 18.9% of participants who might have been excluded from trials based on suicidal ideation and suicide attempt, the CSSRS identified high-risk suicidal ideation or suicide attempt in the preceding 2 years in only 4.4%. Significance Suicidality screening is feasible in people with epilepsy. Slightly more suicidal behavior is reported with the E-CSSRS than C-SSRS, suggesting the E-CSSRS may be optimal. The proportion of patients who may be excluded from clinical trials based on worrisome suicidal ideation or suicide attempt is small, suggesting that it is possible to enroll most eligible individuals.

AB - Summary Purpose Three suicidal ideation and suicidal behavior instruments were used to assess the prevalence of lifetime and recent suicidal ideation and suicidal behavior in patients with frequent treatment-resistant focal seizures who would be eligible for randomized clinical trials. This was done to determine which instrument was optimal for use in epilepsy. Methods In a cross-sectional study, we compared lifetime and recent suicidal ideation and suicide attempt on the MINI International Neuropsychiatric Interview (MINI), Columbia Suicide Severity Rating Scale (C-SSRS), and Interactive Voice Response System CSSRS (E-CSSRS). A safety algorithm determined treatment referral. Coordinators and participants evaluated experiences with the C-SSRS. The proportion of participants that baseline assessment would exclude from clinical trial enrollment was determined. Key Findings Among 208 participants, 1.6-3.9% had recent high risk suicidal ideation and 1.0-4.7% had a recent suicide attempt across all instruments. Lifetime high-risk suicidal ideation occurred in 12.1-14.1%. Lifetime suicide attempt occurred in 10.2-13.1% of participants. Of those with recent suicide attempt, 31.1% required referral to a health professional, and 3.9% needed urgent referral. Lifetime suicidal behavior (including aborted suicide attempt, interrupted suicide attempt, suicide attempt, preparatory acts or behavior, and nonsuicidal self-injurious behavior) was found in 21.1% on the E-CSSRS and 15.5% on the C-SSRS. Agreement (Kappa) was good to excellent for comparisons of all instruments. Fifty-two percent of subjects preferred either the CSSRS or E-CSSRS, whereas the rest had no preference; of those having a preference, 87.5% favored the CSSRS. Of the 18.9% of participants who might have been excluded from trials based on suicidal ideation and suicide attempt, the CSSRS identified high-risk suicidal ideation or suicide attempt in the preceding 2 years in only 4.4%. Significance Suicidality screening is feasible in people with epilepsy. Slightly more suicidal behavior is reported with the E-CSSRS than C-SSRS, suggesting the E-CSSRS may be optimal. The proportion of patients who may be excluded from clinical trials based on worrisome suicidal ideation or suicide attempt is small, suggesting that it is possible to enroll most eligible individuals.

KW - CSSRS

KW - Epilepsy

KW - MINI

KW - Suicidal behavior

KW - Suicidal ideation

UR - http://www.scopus.com/inward/record.url?scp=84876900807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876900807&partnerID=8YFLogxK

U2 - 10.1111/epi.12128

DO - 10.1111/epi.12128

M3 - Article

C2 - 23448169

AN - SCOPUS:84876900807

VL - 54

SP - 879

EP - 887

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 5

ER -